These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 18660839)

  • 1. Discrepancy between disease activity and levels of vascular endothelial growth factor in a patient with POEMS syndrome successfully treated with autologous stem-cell transplantation.
    Goto H; Nishio M; Kumano K; Fujimoto K; Yamaguchi K; Koike T
    Bone Marrow Transplant; 2008 Nov; 42(9):627-9. PubMed ID: 18660839
    [No Abstract]   [Full Text] [Related]  

  • 2. Vascular endothelial growth factor and POEMS.
    Dyck PJ; Engelstad J; Dispenzieri A
    Neurology; 2006 Jan; 66(1):10-2. PubMed ID: 16401837
    [No Abstract]   [Full Text] [Related]  

  • 3. Autologous peripheral blood stem cell transplantation for POEMS syndrome.
    Kuwabara S; Misawa S; Kanai K; Kikkawa Y; Nishimura M; Nakaseko C; Cho RK; Hattori T
    Neurology; 2006 Jan; 66(1):105-7. PubMed ID: 16401856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [POEMS syndrome: monoclonal plasma cell disorder with polyneuropathy].
    Kamezaki K; Nagafuji K
    Nihon Rinsho; 2007 Dec; 65(12):2235-7. PubMed ID: 18069266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skin manifestations and vascular endothelial growth factor levels in POEMS syndrome: impact of autologous hematopoietic stem cell transplantation.
    Barete S; Mouawad R; Choquet S; Viala K; Leblond V; Musset L; Amoura Z; Khayat D; Francès C
    Arch Dermatol; 2010 Jun; 146(6):615-23. PubMed ID: 20566924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relapse of polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes (POEMS) syndrome without increased level of vascular endothelial growth factor following successful autologous peripheral blood stem cell transplantation.
    Imai N; Taguchi J; Yagi N; Konishi T; Serizawa M; Kobari M
    Neuromuscul Disord; 2009 May; 19(5):363-5. PubMed ID: 19269178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bevacizumab therapy before autologous stem-cell transplantation for POEMS syndrome.
    Dietrich PY; Duchosal MA
    Ann Oncol; 2008 Mar; 19(3):595. PubMed ID: 18209011
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment strategy for POEMS syndrome].
    Kawamura N; Kira J
    Brain Nerve; 2008 Jun; 60(6):621-6. PubMed ID: 18567357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Crow-Fukase (POEMS) syndrome].
    Kuwabara S
    Nihon Rinsho; 2015 Sep; 73 Suppl 7():446-51. PubMed ID: 26480740
    [No Abstract]   [Full Text] [Related]  

  • 10. Neurologic improvement after peripheral blood stem cell transplantation in POEMS syndrome.
    Kuwabara S; Misawa S; Kanai K; Suzuki Y; Kikkawa Y; Sawai S; Hattori T; Nishimura M; Nakaseko C
    Neurology; 2008 Nov; 71(21):1691-5. PubMed ID: 18832140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New advances in the diagnosis and treatment of POEMS syndrome.
    Li J; Zhou DB
    Br J Haematol; 2013 May; 161(3):303-15. PubMed ID: 23398538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bevacizumab therapy for Poems syndrome].
    Doffoel-Hantz V; Jaccard A; Sparsa A; Girault S; Bonnetblanc JM; Bordessoule D; Bédane C
    Ann Dermatol Venereol; 2008 Apr; 135(4):320-1. PubMed ID: 18420085
    [No Abstract]   [Full Text] [Related]  

  • 13. [New strategy of treatment for POEMS syndrome--autologous peripheral blood stem cell transplantation and thalidomide therapy].
    Kuwabara S
    Brain Nerve; 2008 Jun; 60(6):627-33. PubMed ID: 18567358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful combination treatment with bevacizumab, thalidomide and autologous PBSC for severe POEMS syndrome.
    Ohwada C; Nakaseko C; Sakai S; Takeda Y; Abe D; Takeuchi M; Sakaida E; Masuda S; Shimizu N; Cho R; Nishimura M; Kanai K; Misawa S; Kuwabara S
    Bone Marrow Transplant; 2009 May; 43(9):739-40. PubMed ID: 19043459
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical characteristics and the long-term outcome of patients with atypical POEMS syndrome variant with undetectable monoclonal gammopathy.
    He T; Zhao A; Zhao H; Cai H; Feng J; Zhang L; Cao X; Zhou D; Li J
    Ann Hematol; 2019 Mar; 98(3):735-743. PubMed ID: 30612232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. POEMS syndrome treated with melphalan high-dose therapy and autologous blood stem cell transplantation: a single-institution experience.
    Thoennissen GB; Thoennissen NH; Fritz F; Hilbig A; Kerkhoff A; Liersch R; Krug U; Koschmieder S; Müller-Tidow C; Mesters R; Kropff M; Berdel WE
    Ann Hematol; 2012 Sep; 91(9):1419-25. PubMed ID: 22543828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of POEMS syndrome with bevacizumab.
    Samaras P; Bauer S; Stenner-Liewen F; Steiner R; Zweifel M; Renner C; Knuth A
    Haematologica; 2007 Oct; 92(10):1438-9. PubMed ID: 18024383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autologous peripheral blood stem cell transplantation and the role of lenalidomide in patients affected by poems syndrome.
    Autore F; Innocenti I; Luigetti M; Piccirillo N; Sora F; Chiusolo P; Sica S; Bacigalupo A; Laurenti L
    Hematol Oncol; 2018 Apr; 36(2):392-398. PubMed ID: 28913957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failure of treatment with anti-VEGF monoclonal antibody for long-standing POEMS syndrome.
    Kanai K; Kuwabara S; Misawa S; Hattori T
    Intern Med; 2007; 46(6):311-3. PubMed ID: 17380000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment sequence incorporating bevacizumab for therapy of polyneuropathy in two patients with POEMS syndrome.
    Buxhofer-Ausch V; Gisslinger B; Stangl G; Rauschka H; Gisslinger H
    Leuk Res; 2012 May; 36(5):e98-e100. PubMed ID: 22365941
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.